Given an abstract, indicate which of the provided candidate titles (Option1 and Option2) best describes it (respond with the text of the title, not option1/2).

Q: Abstract: To evaluate the role of beta-adrenergic receptors in the control of human sweating, we studied six subjects during 40 min of cycle-ergometer exercise (60% maximal O2 consumption) at 22 degrees C 2 h after oral administration of placebo or nonselective beta-blockade (BB, 80 mg propranolol). Internal temperature (esophageal temperature, Tes), mean skin temperature (Tsk), local chest temperature (Tch), and local chest sweat rate (msw) were continuously recorded. The control of sweating was best described by the slope of the linear relationship between msw and Tes and the threshold Tes for the onset of sweating. The slope of the msw-Tes relationship decreased 27% (P less than 0.01), from 1.80 to 1.30 mg X cm-2 X min-1 X degree C-1 during BB. The Tes threshold for sweating (36.8 degrees C) was not altered as the result of BB. These data suggest that BB modified the control of sweating via some peripheral interaction. Since Tsk was significantly (P less than 0.05) reduced during BB exercise, from a control value of 32.8 to 32.2 degrees C, we evaluated the influence of the reduction in local skin temperature (Tsk) in the altered control of sweating. Reductions in Tch accounted for only 45% of the decrease in the slope of the msw-Tes relationship during BB. Since evaporative heat loss requirement during exercise with BB, as estimated from the energy balance equation, was also reduced 18%, compared with control exercise, we concluded that during BB the reduction in sweating at any Tes is the consequence of both a decrease in local Tsk and a direct effect on sweat gland.
Which is the apt title for the abstract? option1: Influence of beta-adrenergic blockade on the control of sweating in humans. option2: Permeability and secondary membrane formation of a high flux polysulfone hemofilter.

A: Influence of beta-adrenergic blockade on the control of sweating in humans.
****
Q: Abstract: This article stresses the fact that the pediatric patient who presents with back pain is very different from the adult patient with the same complaint. A child is much less likely to complain of symptoms when there is no organic cause for the complaint, and therefore his or her status should be evaluated carefully. When an immediate cause is not obvious, repeated examination should be performed because time may reveal a cause of the symptoms.
Which is the apt title for the abstract? option1: Evaluating the child with back pain. option2: Nutrition and cancer II.

A: Evaluating the child with back pain.
****
Q: Abstract: Sixteen adult subjects with asthma in a clinical steady state were studied. On day 1, after baseline spirometry, they underwent four histamine inhalation tests with functional recovery between each test. The provocative concentration causing a 20% fall in FEV1 (PC20) was obtained after each test. On days 2, 3, and 4, after baseline spirometry, active and placebo ascorbic acid (2 gm) was administered orally, double-blind, according to a 4.3.1 two-treatment crossover study design. One hour later, spirometry was performed, and PC20 was reassessed. We found no significant changes in FEV1 and FVC after ascorbic acid as compared with placebo administration. There was no difference between PC20 on days 2, 3, and 4 and by standardizing for the four PC20 results obtained on day 1. We conclude that ascorbic acid has no acute bronchodilator effect and does not alter bronchial responsiveness to histamine in subjects with asthma.
Which is the apt title for the abstract? option1: Lack of acute effects of ascorbic acid on spirometry and airway responsiveness to histamine in subjects with asthma. option2: AIDS drug test [news]

A:
Lack of acute effects of ascorbic acid on spirometry and airway responsiveness to histamine in subjects with asthma.
****